News & Updates
Filter by Specialty:

Fremanezumab helps prevent episodic migraine in youths
21 Apr 2025
byStephen Padilla
The use of fremanezumab is safe and effective for the prevention of episodic migraine (EM) in children and adolescents as young as 6 years old, according to a study presented at AAN 2025.